To further assess whether the Gal‐3 inhibitor enhanced the anti‐PD‐L1 antibody‐mediated promotion of T‐cell cytotoxic activity, we evaluated tumor‐infiltrating lymphocytes (TILs) and their relative activation in tumor tissues derived from mice. This evidence concerns the gene CD274 and neoplasm.